References

  1. Liu C, Crawford JM. The gastrointestinal tract, In: Kumar V, Abbas AK, Fausto N (Eds). Robbins and Cotran Pathologic Basis of Disease. Pennsylvania, Elsevier. 2005; 7th ed: 813-816. Google Scholar

  2. Powell SM. Stomach cancer, in: Vogelstein B, Kinzler W(Eds). The Genetic Basis of Human Cancer. New York, McGraw-Hill Co. 2002: 2nd ed: 703-708. Google Scholar

  3. El-Rifai W, Powell SM. Molecular biology of gastric cancer. Semin Radiat Oncol. 2002;12:128. PubMed | Google Scholar

  4. Matsukur N, Suzuki K, Kawachi T, Aoyagi M, Sugimura T et al.Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incompletetypes of intestinal metaplasia to minute gastric carcinomas.J Natl Cancer Inst. 1980; 65(2):231-240. PubMed | Google Scholar

  5. Leung WK, Lin SR, Ching JYL, To KF, Hg EKW et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomized trial on Helicobacter pylorieradication.Gut. 2004;53(9):1244-1249. PubMed | Google Scholar

  6. Rubio CA, Befrits R. Gastric intestinal metaplasia. J ClinPathol. 2004; 57(8):894-895. PubMed | Google Scholar

  7. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992; 33(1):16-20. PubMed | Google Scholar

  8. Sharma P, Weston AP, Morales T, Topalovski M, Mayo MS, Sampliner RE. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut. 2000; 46(1):9-13. PubMed | Google Scholar

  9. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V et al. Intestinal metaplasia ypes and the risk of gastric cancer: A cohort study in Slovenia. Int J Cancer. 1994; 57(3):324-32. PubMed | Google Scholar

  10. El-Zimaity HMT, Ramchatesingh J, Ali-Saeed M, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J ClinPathol. 2001; 54(9):679-683. PubMed | Google Scholar

  11. Sabageh D Ojo OS, Adelusola KA. Gastric carcinoma: A review of the histopathological features of cases seen at Ile-Ife, Nigeria. Annals of Tropical Pathology. 2010; 1(1):27-34. PubMed | Google Scholar

  12. Arigbabu AO. Gastric cancer in Nigeria. Topical Doctor. 1998; 18:13-15. PubMed | Google Scholar

  13. Abioye AA, Hendrickse M, Junaid TA. Ibadan Cancer Registry 1970-1976, In Parkin DM: Cancer Occurrence I developing countries. IARC. 1986;67-71. PubMed | Google Scholar

  14. Oluwasola AO, Ogunbiyi JO. Gastric cancer: aetiological, clinicopathological and management patterns in Nigeria. Niger J Med. 2003; 12(4):177-186. PubMed | Google Scholar

  15. Obakpite PO, Onuminya JE, Nwana EJC, Anteyi EA, Malu AO et al. A clinicopathological review of gastric malignancies in the middle belt of Nigeria. Nig Med Pract. 1994; 27(6):69-72. PubMed | Google Scholar

  16. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol. 1996; 20(10):1168-1181. PubMed | Google Scholar

  17. Rameshar K, Danders D, Hapwood D. Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J ClinPathol. 1987; 40:1287-1290. PubMed | Google Scholar

  18. Central Intelligence Agency: The World Factbook; [https://www.cia.gov/library/publications/ the-world-factbook/geos/ni.html]. Access on August 03 2015. Google Scholar